SCHEMBL21034940

SCHEMBL21034940

O=C(O)[C@H]1CCCCN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
HTT P42858 1/20 0.55
KDM4E B2RXH2 1/20 0.54
HSD17B10 Q99714 1/20 0.54
HCRTR1 O43613 3/20 0.47
HCRTR2 O43614 3/20 0.47
MMP1 P03956 1/20 0.47
MMP3 P08254 1/20 0.47
MMP7 P09237 1/20 0.47
MMP13 P45452 1/20 0.47
PLAU P00749 1/20 0.46
LMNA P02545 2/20 0.45
TSHR P16473 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ITGB1 P05556 1/20 0.44
ITGA4 P13612 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CCR4 P51679 2/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21034938 1.00 ALDH1A1 (0.55) ALDH1A1HTTKDM4EHSD17B10HCRTR1
SCHEMBL21035533 0.88 CASP3 (0.56) ALDH1A1HCRTR1HCRTR2MMP1MMP3
SCHEMBL21035666 0.85 ITGB1 (0.49) ALDH1A1HTTKDM4EHSD17B10HCRTR1
SCHEMBL2977236 0.84 ALDH1A1 (0.61) ALDH1A1HTTKDM4EHSD17B10HCRTR1
SCHEMBL2977241 0.84 ALDH1A1 (0.61) ALDH1A1HTTKDM4EHSD17B10HCRTR1
SCHEMBL21035534 0.84 GHSR (0.55) ALDH1A1LMNATSHRNPSR1MEN1
SCHEMBL21035523 0.83 AKR1C3 (0.43) KDM4EHSD17B10HCRTR1HCRTR2MMP1
SCHEMBL21035001 0.82 ITGB1 (0.47) HTTKDM4EHSD17B10HCRTR1HCRTR2
SCHEMBL21035399 0.81 HTR1A (0.44) KDM4EHSD17B10HCRTR1HCRTR2MMP1
SCHEMBL21035314 0.81 HTR1A (0.44) KDM4EHSD17B10HCRTR1HCRTR2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed